인쇄하기
취소

Products like ‘Repatha Inj’ & ‘Soolantra Cream 1%’ enter Asan Medical Center

Published: 2018-02-27 16:26:11
Updated: 2018-02-27 16:26:11

Amgen’s ‘Repatha Inj’ and Galderma’s ‘Soolantra Cream 1%’ entered Asan Medical Center.

At the 142nd Drug Committee, Asan Medical Center approved introduction of ‘Repatha Inj,’ the Amgen Korea’s PCSK9-inhibiting cholesterol treatment, and ‘Soolantra Cream 1%,’ the Galderma Korea’s local inflammatory lesion treatment. In addition, ‘Fytarex Cap 0.5mg,’ the Sandos Korea’s multiple arteriosclerosis...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.